What Akash Ambani said on Jio tariff hikes ahead of record IPO launch
Akash Ambani said Jio can raise mobile tariffs but prefers growing revenue through digital services, broadband and enterprise solutions. Ahead of its Rs 30,213 crore IPO, Jio aims to expand margins and connect 100 million homes.
Wipro Q2 Results: Net profit declines marginally YoY to Rs 3,201 crore, but revenue rises 9%
Wipro Q2 Results: Wipro reported a 1.4% year-on-year decline in Q2FY27 net profit to Rs 3,201 crore, while revenue rose 9.1% to Rs 24,752.7 crore. IT services revenue increased 0.3% to $2,611.5 million, while operating margin expanded 0.5 percentage points sequentially to 16.5%. The company expects IT services revenue to decline up to 1.5% or […]
Nilesh Shah on PSU privatisation: How Hindustan Zinc offers a lesson for IDBI Bank
Kotak AMC’s Nilesh Shah cited Hindustan Zinc as an example of how strategic divestment combined with a retained minority stake can create long-term national wealth. He said the government’s remaining stake is now worth over Rs 62,000 crore and expressed hope that IDBI Bank’s divestment would deliver similar value.
US stocks: Dow, S&P 500 end higher as traders shift from AI to healthcare
After a rocky start, the S&P 500 experienced a resurgence, largely spurred by investments in the healthcare and consumer segments. Investors seemed to distance themselves from technology stocks, anxious about mounting debts in the AI sector. Eli Lilly and UnitedHealth rose thanks to favorable evaluations from Deutsche Bank, whereas Broadcom and Nvidia struggled.
Beware! Blind investing in smallcaps won’t make you money as 148 of 250 stocks tumble in 2026
More than half of the Nifty 250 stocks have delivered negative returns in 2026 despite the index gaining over 7%. Experts flag elevated valuations and persistent FII selling, stressing selective stock picking as earnings growth and performance diverge across market segments.
Canara Bank shares slide over 6% after Q2 earnings. Buy, sell or hold the state lender?
Canara Bank shares fell sharply on Thursday despite reporting an 8% year-on-year rise in Q2 FY27 standalone net profit to Rs 5,175 crore. Brokerages remain divided, with Morgan Stanley retaining an Underweight rating, while Motilal Oswal and JM Financial recommend buying the stock.
BHEL shares fall 4% despite Q2 profit jumping 119% YoY. Should you buy, sell or hold?
BHEL shares fell 4.3% after rallying on strong Q2FY27 results, even as Nuvama and JM Financial retained their Buy ratings and raised target prices. Brokerages cited margin expansion, improved execution, a healthy order book and favourable thermal power prospects.
Rs 82,500 crore rally in 3 days: Why TCS, HCL Tech, other IT stocks jumped up to 12% in 3 days and will the boom last?
Indian IT stocks have rebounded sharply. The Nifty IT index has risen 8%, adding Rs 82,500 crore to the sector’s market capitalisation. The rebound follows a selloff in global AI-linked stocks driven by concerns over stretched valuations, concentration risks and uncertain returns on heavy AI investments.
IDBI Bank shares fall 7% as investors book profit after Fairfax deal gets cabinet nod
IDBI Bank shares plunged as investors booked profits after a nearly 13% rally in the previous session following the Cabinet’s approval of Fairfax’s acquisition of a 60.72% stake in the lender. The stock had hit Rs 93.60 on Wednesday, lifting its market capitalisation above Rs 1 lakh crore. The Rs 52,878 crore deal marks a […]
Sahajanand Medical Technologies IPO opens for subscription. Check GMP, price band and key details
Sahajanand Medical Technologies IPO opened for subscription on October 15, 2026, aiming to raise Rs 475.48 crore through an entirely offer-for-sale issue. The price band is set at Rs 327-344 per share, with a lot size of 43 shares. The issue commands a 12% grey market premium.